Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam® 2023-11-14 06:33
Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery 2023-11-13 16:27
First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591 2023-11-13 07:38
Telix to Present at Jefferies London Healthcare Conference 2023 2023-11-09 04:51
Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region 2023-11-08 13:00
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability 2023-10-19 06:01
Telix reports fourth consecutive quarter of positive operating cash flow 2023-10-18 15:42
HRH Princess Astrid of Belgium visits Telix's New European Manufacturing Facility in Brussels South 2023-09-27 12:00
Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM 2023-09-06 14:18
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company 2023-08-23 17:40
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 11:14
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 07:18
First Patient Dosed in IPAX-2 Study of TLX101 Brain Cancer Therapy Candidate in Patients with Newly Diagnosed Glioblastoma 2023-08-08 06:24
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow 2023-07-19 16:14
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib 2023-07-19 05:00
New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC 2023-06-27 03:51
Telix to Showcase ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline Developments at SNMMI 2023-06-22 19:00
Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical 2023-06-21 17:32
Telix Urology Innovation Showcase to be held at The Yale Club, New York City 2023-06-21 06:31
First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion 2023-06-19 08:16
1 3 4 5 6 7 9